期刊文献+

反义核酸hTERT对大肠癌细胞的抑制作用 被引量:1

Construction of antisense hTERT retroviral vector and its inhibition on the proliferation of HT29 colorectal cancer cells
下载PDF
导出
摘要 目的 :构建人端粒酶逆转录酶组分 (humantelomerasereversetranscriptase ,hTERT)反义cDNA逆转录病毒载体 ,观察其对大肠癌细胞HT2 9端粒酶活性和细胞增殖的抑制作用 ,探讨以hTERT为靶的大肠癌基因治疗的可行性。方法 :RT PCR扩增hTERTmRNA 5′起始端 835bp的cDNA ,分别正向和反向插入到逆转录病毒表达载体 pLXSN质粒中 ,转染包装细胞PT6 7后获得重组病毒 ,病毒感染大肠癌HT2 9细胞。处理前后采用Westernblot检测hTERT蛋白表达 ,TRAP法检测端粒酶活性 ,倒置显微镜观察细胞形态变化 ,绘制细胞生长曲线 ,流式细胞仪和DNA片段电泳观察凋亡情况。结果 :反义hTERT作用大肠癌HT2 9细胞后hTERT表达下降 ,端粒酶活性被抑制 ,细胞增殖受到抑制并出现明显的细胞凋亡。结论 :反义hTERT对大肠癌细胞HT2 9端粒酶活性具有明显的抑制作用 ,抑制细胞生长 ,促进细胞凋亡 ,hTERT有可能成为大肠癌基因治疗靶点。 Objective: To construct the antisense human telomerase reverse transcriptase (hTERT) cDNA retroviral vector, investigate the inhibition of telomerase activity and celluler proliferation in colorectal cancer cells HT29 by it treatment. and explore the possibility of the hTERT as a target for colorectal cancer gene therapy. Methods:We used RT PCR amplify the hTERT mRNA 5′ region 835bp fragment, and cloned the hTERT fragment into pLXSN retroviral vector in sense and antisense orientations. The replication deficient retroviruses were by obtained transfecting the packing cells of PT67, and then infecting the HT29 colorectal cancer cells. The hTERT protein expression was detected by Western blot, telomerase activity was determined by telomerase repeat amplification protocol (TRAP), cell proliferation was investigated by invert microscope and growth curve, and the apoptosis was characterized by flow cytometry and DNA electrophoresis. Results: Compared with the sense hTERT transduced HT29, the hTERT protein expression, telomerase activity and cell proliferation of HT29 were significantly inhibited and apoptosis occurred after antisense hTERT transduction. Conclusion: The transduction of antisense hTERT can significantly inhibit the hTERT expression, suppress telomerase activity, arrest the cell growth and accelerate apoptosis in HT29. hTERT is a potential target for colorectal cancer gene therapy.
出处 《北京大学学报(医学版)》 CAS CSCD 北大核心 2002年第6期692-695,共4页 Journal of Peking University:Health Sciences
基金 国家自然科学基金资助课题 (3 9870 840 )~~
关键词 人端粒酶逆转录酶 大肠癌细胞 肿瘤细胞 细胞培养 药物作用 细胞凋亡 Human telomerase reverse transcriptase Colonic neoplasms Tumor cells,cultured/drug eff Apoptosis
  • 相关文献

参考文献6

  • 1徐文怀,鞠晓明,李涵.大肠癌组织和正常黏膜中端粒酶活性表达及临床意义[J].北京大学学报(医学版),2001,33(1):10-12. 被引量:4
  • 2Zhang XL, Vernon M, Zhou W, et al. Telomere shortening and apoptosis in telomerase-inhibited human tumor cells[J]. Genes Dev, 1999,13(8):2388-2399
  • 3Bisoffi M, Chakerian AE, Fore ML, et al. Inhibition of human telomerase by a retrovirus expressing telomeric antisense RNA[J]. Eur J Cancer, 1998,34(8):1242-1249
  • 4Meyerson M, Counter CM, Eaton EN, et al. hEST2, the putative human telomerase catalytic subunit gene, is up-regulated in tumor cells and during immortalization[J]. Cell, 1997,90:785-795
  • 5Yokoyama Y, Takahashi Y, Shinohara A, et al. The 5′-end of hTERT mRNA is a good target for hammerhead ribozyme to suppress telomerase activity[J]. Biochem Biophys Res Commun, 2000,273:316-321
  • 6Rosenberg SA, Anderson WF, Blaese M, et al. The development of gene therapy for the treatment of cancer[J]. Ann Surg, 1993,216: 455-463

二级参考文献12

  • 1[1]Kim NW, Piatyszek MA, Prowse KR, et al. Specific association of human telomerase activity with immortal cells and cancer [J] .Science, 1994; 266:2011-2015
  • 2[2]Rhyu M. Telormerase, telomerase, immortality [J]. J Natl Cancer Inst, 1995, 87:885-894
  • 3[3]Hiyama E, Gollahon L, Kataoka T, et al. Telomerase activity in human breast tumors [J]. J Natl Cancer Inst, 1996, 17:116-122
  • 4[4]Shay JW, Bacchetti S. A survey of telomerase activity in human cancer [J]. EurJ Cancer, 1997,33:787-791
  • 5[5]Hiyama E, Hiyama K, Yokoyama T, et al. Correlating telomeraser activity levels with human neuroblastoma outcomes [J ]. Nature Med, 1995, ( 1 ): 249-255
  • 6[6]Engelhardt M, Drullinsky P, Guillem J. Telomerase and telomere length in the development and progression of premalignant lesions to colorectal cancer [J]. Clin Cancer Res, 1997, 3:1931-1941
  • 7[7]Engelhardt M, Albanell J, Drullinsky P, et al. Relative contribution of normal and neoplastic cells determines telomerase activity and telomere length in primary cancers of the prostate, colon, and sarcoma [J] . Clin Cancer Res, 1997,3:1849-1857
  • 8[8]Hiyama E, Yokoyama T, Tatsumoto N, et al. Telomerase activity in gastric cancer [J]. Cancer Res, 1995, 55:3258-3262
  • 9[9]Blasco M, Rizen M, Greider C, et al. Differential regulation of telomerase activity and telomerase RNA during multi-stage tumorigenesis [J]. Nature Genet, 1996,12:200-204
  • 10[10]Avilion A, Piayszek A, Gupta J, et al. Human telomerase RNA and telomerase activity in immortal cell lines and tumor tissues [J ].Cancer Res, 1996,56:645-650

共引文献3

同被引文献5

引证文献1

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部